camptothecin has been researched along with Carcinoma, Lewis Lung in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (13.33) | 18.2507 |
| 2000's | 4 (26.67) | 29.6817 |
| 2010's | 8 (53.33) | 24.3611 |
| 2020's | 1 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, H; Huang, Z; Li, F; Li, J; Su, Y; Yan, L; Zhang, Q; Zheng, Y | 1 |
| Jin, X; Lei, J; Li, T; Lu, H; Sheng, Y; Wang, S; Zhang, F; Zhang, Q; Zheng, Y | 1 |
| Chen, H; Du, W; Li, G; Li, M; Liang, X; Yang, W; Zhang, C; Zhang, W | 1 |
| Edwards, AD; Greenbaum, JM; Hariri, G; Harth, E; Merrill, TB; van der Ende, AE | 1 |
| Andrejecsk, JW; Deng, Y; Hoimes, CJ; Saltzman, WM; Saucier-Sawyer, JK; Seo, YE; Zhang, J | 1 |
| Hirano, S; Kuroda, A; Kuwatani, T; Kyogoku, N; Maki, T; Miyauchi, K; Shichinohe, T; Takeuchi, S; Tsuchikawa, T; Wada, M; Yamamura, Y | 1 |
| Colson, YL; Falde, EJ; Freedman, JD; Grinstaff, MW; Herrera, VL; Yohe, ST | 1 |
| Lesnaia, NA; Pokrovskiĭ, VS; Romanenko, VI; Treshchalina, EM | 1 |
| Chirieac, LR; Colson, YL; Grinstaff, MW; Liu, R; Walpole, J; Wolinsky, JB | 1 |
| Ayuzawa, R; Doi, C; Maurya, DK; Tamura, M; Troyer, D | 1 |
| Saiki, I | 1 |
| Jiang, W; Larrick, JW; Li, L; Wang, Y | 1 |
| Anderson, RC; Babel, KM; Brat, DJ; Brem, H; Ewend, MG; Pinn, ML; Tabassi, K; Tyler, BM; Williams, JA | 1 |
| Hirota, S; Hirotsu, S; Sadzuka, Y | 1 |
| Ikeda, T; Mitani, N; Murakami, K; Saiki, I; Yamaura, T | 1 |
15 other study(ies) available for camptothecin and Carcinoma, Lewis Lung
| Article | Year |
|---|---|
Redox-sensitive lipophilic prodrugs: delivering unstable chemotherapeutant for improved cancer therapy.
Topics: Animals; Antineoplastic Agents; Camptothecin; Carcinoma, Lewis Lung; Cell Line, Tumor; Drug Delivery Systems; Glutathione; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Micelles; Oxidation-Reduction; Particle Size; Prodrugs; Rats; Rats, Sprague-Dawley; Tissue Distribution | 2019 |
Drug Release from Disulfide-Linked Prodrugs: Role of Thiol Agents.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Camptothecin; Carcinoma, Lewis Lung; Cells, Cultured; Disulfides; Drug Delivery Systems; Drug Liberation; Fibroblasts; Glutathione; Mice; Nanoparticles; Oleic Acid; Prodrugs; Sulfhydryl Compounds | 2021 |
Tissue Distribution and Anti-Lung Cancer Effect of 10-Hydroxycamptothecin Combined with Platycodonis Radix and Glycyrrhizae Radix ET Rhizoma.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Camptothecin; Carcinoma, Lewis Lung; Chromatography, Liquid; Cytokines; Disease Models, Animal; Drug Monitoring; Drugs, Chinese Herbal; Glycyrrhiza; Lung Neoplasms; Male; Mice; Plant Roots; Rhizome; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Tissue Distribution; Xenograft Model Antitumor Assays | 2019 |
Sequential targeted delivery of paclitaxel and camptothecin using a cross-linked "nanosponge" network for lung cancer chemotherapy.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Camptothecin; Carcinoma, Lewis Lung; Cell Cycle; Cell Proliferation; Cross-Linking Reagents; Drug Carriers; Drug Delivery Systems; Humans; Immunoenzyme Techniques; Lung Neoplasms; Male; Mice; Mice, Inbred C57BL; Mice, Nude; Microscopy, Electron, Transmission; Nanoparticles; Paclitaxel; Peptide Fragments; Radiation, Ionizing; Tumor Cells, Cultured | 2014 |
The effect of hyperbranched polyglycerol coatings on drug delivery using degradable polymer nanoparticles.
Topics: Animals; Camptothecin; Carcinoma, Lewis Lung; Cell Death; Cell Proliferation; Coated Materials, Biocompatible; Drug Delivery Systems; Endocytosis; Immunohistochemistry; Mice; Nanoparticles; Particle Size; Polyethylene Glycols; Polymers | 2014 |
The key role of calreticulin in immunomodulation induced by chemotherapeutic agents.
Topics: Animals; Antigens, Surface; Antineoplastic Agents; Apoptosis; Calreticulin; Camptothecin; Carcinoma, Lewis Lung; CD3 Complex; Cell Line, Tumor; Cell Survival; Cisplatin; Colonic Neoplasms; Deoxycytidine; Female; Fluorouracil; Gemcitabine; Histocompatibility Antigens Class I; Humans; Immunomodulation; Lymphocyte Count; Melanoma, Experimental; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mitomycin; Mitoxantrone; Neoplasm Transplantation; Neoplasms, Experimental; Protein Transport; T-Lymphocytes; Tumor Microenvironment | 2015 |
Layered superhydrophobic meshes for controlled drug release.
Topics: Animals; Antineoplastic Agents, Phytogenic; Camptothecin; Carcinoma, Lewis Lung; Cell Line, Tumor; Delayed-Action Preparations; Drug Delivery Systems; Hydrophobic and Hydrophilic Interactions; Irinotecan; Neoplasm Recurrence, Local; Polyesters; Rats; Rats, Inbred Lew; Solubility; Surface Properties | 2015 |
[Pre-clinical study of combined aranosa, cisplatin and irinotecan in the treatment of experimental lung cancer].
Topics: Animals; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Lewis Lung; Cisplatin; Drug Administration Schedule; Glycosides; Irinotecan; Male; Methylnitrosourea; Mice; Mice, Inbred C57BL; Mice, Inbred Strains | 2009 |
Prevention of in vivo lung tumor growth by prolonged local delivery of hydroxycamptothecin using poly(ester-carbonate)-collagen composites.
Topics: Animals; Antineoplastic Agents, Phytogenic; Camptothecin; Carcinoma, Lewis Lung; Cell Line, Tumor; Cell Proliferation; Cell Survival; Collagen; Delayed-Action Preparations; Drug Carriers; Drug Compounding; Mice; Microscopy, Electron, Scanning; Neoplasm Recurrence, Local; Polyesters; Surface Properties; Tissue Scaffolds | 2010 |
Topoisomerase I inhibitor SN-38 effectively attenuates growth of human non-small cell lung cancer cell lines in vitro and in vivo.
Topics: Animals; Antineoplastic Agents, Alkylating; Apoptosis; Camptothecin; Carcinoma, Lewis Lung; Carcinoma, Non-Small-Cell Lung; Caspase 3; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Female; Humans; Irinotecan; Lung Neoplasms; Membrane Potential, Mitochondrial; Mice; Mice, Inbred C57BL; Poly(ADP-ribose) Polymerases; Topoisomerase I Inhibitors | 2011 |
[Screening for inhibitors of tumor invasion into basement membranes].
Topics: Animals; Basement Membrane; Berberine; Camptothecin; Carcinoma, Lewis Lung; Cell Movement; Drug Screening Assays, Antitumor; Humans; Irinotecan; Lymphatic Metastasis; Mice; Neoplasm Invasiveness; Neoplastic Cells, Circulating; Saponins; Tumor Cells, Cultured | 2004 |
Synthesis and evaluation of a DHA and 10-hydroxycamptothecin conjugate.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Camptothecin; Carcinoma, Lewis Lung; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Disease Models, Animal; Docosahexaenoic Acids; Drug Design; Drug Screening Assays, Antitumor; Humans; Leukemia L1210; Mice; Molecular Conformation; Stereoisomerism; Structure-Activity Relationship | 2005 |
Local delivery of chemotherapy and concurrent external beam radiotherapy prolongs survival in metastatic brain tumor models.
Topics: Animals; Antineoplastic Agents; Brain; Brain Neoplasms; Camptothecin; Carboplatin; Carcinoma; Carcinoma, Lewis Lung; Carmustine; Colonic Neoplasms; Combined Modality Therapy; Female; Humans; Melanoma, Experimental; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Neoplasm Transplantation; Polymers; Radiotherapy Dosage; Tumor Cells, Cultured | 1996 |
Effective irinotecan (CPT-11)-containing liposomes: intraliposomal conversion to the active metabolite SN-38.
Topics: Animals; Antineoplastic Agents, Phytogenic; Biotransformation; Camptothecin; Carcinoma, Lewis Lung; Drug Carriers; Irinotecan; Liposomes; Male; Mice; Tissue Distribution | 1999 |
Inhibitory effect of berberine on the mediastinal lymph node metastasis produced by orthotopic implantation of Lewis lung carcinoma.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Berberine; Camptothecin; Carcinoma, Lewis Lung; Disease Models, Animal; Female; Irinotecan; Lung Neoplasms; Lymphatic Metastasis; Mediastinal Neoplasms; Mice; Mice, Inbred C57BL; Neoplasm Invasiveness; Neoplasm Transplantation; Transcription Factor AP-1 | 2001 |